{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:11:16Z","timestamp":1790151076353,"version":"4.0.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2 OD036435"],"award-info":[{"award-number":["OT2 OD036435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2 OD030544"],"award-info":[{"award-number":["OT2 OD030544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA282657"],"award-info":[{"award-number":["R01 CA282657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited treatment options and response to immune checkpoint inhibitors. Tumor-infiltrating lymphocytes have been extensively studied; however, the integration of peripheral immune dynamics with mechanistic regulation underlying therapeutic response remain poorly defined. Here, we integrate immune-state modeling with pathway-level mechanistic inference to analyze single-cell RNA sequencing of PBMCs from patients with advanced TNBC treated with paclitaxel alone or in combination with the anti\u2013PD-L1 Ab atezolizumab. This framework leverages treatment arm, longitudinal sampling, and clinical response to resolve coordinated immune programs across lymphoid and myeloid compartments. We identified distinct treatment- and response-specific states before and after treatment. Chemotherapy responders displayed pretreatment adaptive immune priming, whereas combination-therapy responders exhibited preexisting effector T-cell activity coupled with tumor PD-L1 expression. In contrast, chemotherapy nonresponders developed persistent post-treatment immune dysregulation in regulatory and terminal effector programs, whereas combination-therapy nonresponders demonstrated maladaptive remodeling of adaptive and innate compartments, including dysfunctional NK and metabolically reprogrammed myeloid populations. Across regimens, pathways involving protein translation, metabolic adaptation, and stress signaling emerged as shared modulators of response. These findings suggest that coordinated adaptive-innate immune dynamics underlie therapeutic efficacy, whereas systemic immune exhaustion and myeloid immunoregulation lead to resistance. Projection of these peripheral immune programs onto independent I-SPY2 showed concordant associations with tumor immune phenotypes and pathological complete response, supporting generalizability of the findings. Our study demonstrates the utility of an integrative approach for linking peripheral immune state organization with mechanistic insights, informing response in TNBC.<\/jats:p>","DOI":"10.1093\/immhor\/vlag049","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:56:10Z","timestamp":1790121370000},"source":"Crossref","is-referenced-by-count":0,"title":["Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemoimmunotherapy in triple-negative breast cancer"],"prefix":"10.1093","volume":"10","author":[{"given":"Zahra","family":"Mesrizadeh","sequence":"first","affiliation":[{"name":"Department of Bioengineering, University of California San Diego , La Jolla, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Mukund","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of California San Diego , La Jolla, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-4659","authenticated-orcid":false,"given":"Shankar","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of California San Diego , La Jolla, CA,","place":["United States"]},{"name":"Departments of Cellular & Molecular Medicine, Computer Science & Engineering, and Data Science, University of California San Diego , La Jolla, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026092303471092200_vlag049-B1","doi-asserted-by":"crossref","first-page":"738073","DOI":"10.3389\/fimmu.2021.738073","article-title":"Immune response in severe and non-severe coronavirus disease 2019 (COVID-19) infection: a mechanistic landscape","volume":"12","author":"Mukund","year":"2021","journal-title":"Front Immunol"},{"key":"2026092303471092200_vlag049-B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"2026092303471092200_vlag049-B3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13058-024-01848-z","article-title":"Pretreatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer","volume":"26","author":"Leon-Ferre","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2026092303471092200_vlag049-B4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/cancers14051331","article-title":"negative relationship between post-treatment stromal tumor-infiltrating lymphocyte (TIL) and survival in triple-negative breast cancer patients treated with dose-dense dose-intense neoadjuvant chemotherapy","volume":"14","author":"Giacchetti","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026092303471092200_vlag049-B5","doi-asserted-by":"publisher","first-page":"e40845","DOI":"10.1097\/MD.0000000000040845","article-title":"Lymphocyte infiltration in breast cancer: a promising prognostic indicator","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"key":"2026092303471092200_vlag049-B6","doi-asserted-by":"publisher","first-page":"111874","DOI":"10.1016\/j.celrep.2022.111874","article-title":"CD4+ T cells drive an inflammatory, TNF-\u03b1\/IFN-rich tumor microenvironment responsive to chemotherapy","volume":"41","author":"Tilsed","year":"2022","journal-title":"Cell Rep"},{"key":"2026092303471092200_vlag049-B7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"key":"2026092303471092200_vlag049-B8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","article-title":"Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"2026092303471092200_vlag049-B9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2026092303471092200_vlag049-B10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4049\/jimmunol.2200887","article-title":"Transendothelial migration of human B cells: chemokine versus antigen","volume":"211","author":"Wang","year":"2023","journal-title":"J Immunol"},{"key":"2026092303471092200_vlag049-B11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","article-title":"Redefining breast cancer subtypes to guide treatment prioritization and maximize response: predictive biomarkers across 10 cancer therapies","volume":"40","author":"Wolf","year":"2022","journal-title":"Cancer Cell"},{"key":"2026092303471092200_vlag049-B12","doi-asserted-by":"publisher","first-page":"rs.3.rs-6926989","DOI":"10.21203\/rs.3.rs-6926989\/v1","article-title":"Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer","author":"Balko","year":"2025","journal-title":"Res Sq"},{"key":"2026092303471092200_vlag049-B13","doi-asserted-by":"publisher","first-page":"107051","DOI":"10.1016\/j.imlet.2025.107051","article-title":"Innate lymphoid cells: dual roles and therapeutic opportunities in breast cancer","volume":"276","author":"Moji\u0107","year":"2025","journal-title":"Immunol Lett"},{"key":"2026092303471092200_vlag049-B14","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","article-title":"Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance","volume":"29","author":"Chu","year":"2023","journal-title":"Nat Med"},{"key":"2026092303471092200_vlag049-B15","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.3390\/ijms21218011","article-title":"CD4 T helper cell subsets and related human immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026092303471092200_vlag049-B16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2026092303471092200_vlag049-B17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"2026092303471092200_vlag049-B18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"2026092303471092200_vlag049-B19","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From Louvain to Leiden: guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci Rep"},{"key":"2026092303471092200_vlag049-B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"2026092303471092200_vlag049-B21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2026092303471092200_vlag049-B22","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026092303471092200_vlag049-B23","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026092303471092200_vlag049-B24","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026092303471092200_vlag049-B25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2026092303471092200_vlag049-B26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2026092303471092200_vlag049-B27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"2026092303471092200_vlag049-B28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41591-023-02370-z","article-title":"Stress response in tumor-infiltrating T cells is linked to immunotherapy resistance","volume":"29","year":"2023","journal-title":"Nat Med"},{"key":"2026092303471092200_vlag049-B29","doi-asserted-by":"crossref","first-page":"747863","DOI":"10.3389\/fcell.2021.747863","article-title":"Targeting metabolic pathways of myeloid cells improves cancer immunotherapy","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026092303471092200_vlag049-B30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/febs.14288","article-title":"Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy","volume":"285","author":"Porta","year":"2018","journal-title":"FEBS J"},{"key":"2026092303471092200_vlag049-B31","doi-asserted-by":"publisher","first-page":"188671","DOI":"10.1016\/j.bbcan.2021.188671","article-title":"A Darwinian perspective on tumor immune evasion","volume":"1877","author":"Puleo","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026092303471092200_vlag049-B32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/2326-6066.CIR-15-0004","article-title":"SOCS3 deficiency in myeloid cells promotes tumor development: involvement of STAT3 activation and myeloid-derived suppressor cells","volume":"3","author":"Yu","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2026092303471092200_vlag049-B33","doi-asserted-by":"publisher","first-page":"e16825","DOI":"10.7717\/peerj.16825","article-title":"Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment","volume":"12","author":"Cheng","year":"2024","journal-title":"PeerJ"},{"key":"2026092303471092200_vlag049-B34","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1073\/pnas.0804286105","article-title":"CXCR4\u2013CCR5: a couple modulating T cell functions","volume":"105","author":"Contento","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026092303471092200_vlag049-B35","doi-asserted-by":"publisher","first-page":"e010871","DOI":"10.1136\/jitc-2024-010871","article-title":"Immunosuppressive microenvironment of liver restrains chemotherapeutic efficacy in triple-negative breast cancer","volume":"13","author":"Liu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026092303471092200_vlag049-B36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","article-title":"Exploiting innate immunity for cancer immunotherapy","volume":"22","author":"Yi","year":"2023","journal-title":"Mol Cancer"},{"key":"2026092303471092200_vlag049-B37","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026092303471092200_vlag049-B38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni.2891","article-title":"Translational control of immune responses: from transcripts to translatomes","volume":"15","author":"Piccirillo","year":"2014","journal-title":"Nat Immunol"},{"key":"2026092303471092200_vlag049-B39","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","article-title":"Spatial predictors of immunotherapy response in triple-negative breast cancer","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"2026092303471092200_vlag049-B40","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.molcel.2021.05.018","article-title":"Translation stress and collided ribosomes are co-activators of cGAS","volume":"81","author":"Wan","year":"2021","journal-title":"Mol Cell"},{"key":"2026092303471092200_vlag049-B41","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/cancers13133357","article-title":"Tumor microenvironment: key players in triple negative breast cancer immunomodulation","volume":"13","author":"Zheng","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026092303471092200_vlag049-B42","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2026092303471092200_vlag049-B43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2026092303471092200_vlag049-B44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2026092303471092200_vlag049-B45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","article-title":"Breast tumor microenvironment structures are associated with genomic features and clinical outcome","volume":"54","author":"Danenberg","year":"2022","journal-title":"Nat Genet"},{"key":"2026092303471092200_vlag049-B46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"2026092303471092200_vlag049-B47","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1182\/blood-2010-11-317321","article-title":"Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells","volume":"117","author":"Hoechst","year":"2011","journal-title":"Blood"},{"key":"2026092303471092200_vlag049-B48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026092303471092200_vlag049-B49","doi-asserted-by":"publisher","first-page":"eabl4414","DOI":"10.1126\/scitranslmed.abl4414","article-title":"Immature natural killer cells promote progression of triple-negative breast cancer","volume":"15","author":"Thacker","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026092303471092200_vlag049-B50","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"2026092303471092200_vlag049-B51","doi-asserted-by":"publisher","first-page":"101511","DOI":"10.1016\/j.xcrm.2024.101511","article-title":"A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response","volume":"5","author":"Xu","year":"2024","journal-title":"Cell Rep Med"}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/10\/9\/vlag049\/71320520\/vlag049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/10\/9\/vlag049\/71320520\/vlag049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:47:18Z","timestamp":1790149638000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/doi\/10.1093\/immhor\/vlag049\/8829092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/immhor\/vlag049","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"vlag049"}}